You have 9 free searches left this month | for more free features.

cemdisiran

Showing 1 - 11 of 11

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Paroxysmal Nocturnal Hemoglobinuria Trial (Pozelimab, Cemdisiran)

Available
  • Paroxysmal Nocturnal Hemoglobinuria
  • (no location specified)
Aug 31, 2023

Paroxysmal Nocturnal Hemoglobinuria Trial (Pozelimab, Cemdisiran)

Not yet recruiting
  • Paroxysmal Nocturnal Hemoglobinuria
  • (no location specified)
Feb 22, 2023

Healthy Trial in London (Pozelimab, Cemdisiran)

Completed
  • Healthy
  • London, United Kingdom
    Regeneron Research Site
Jul 1, 2022

Paroxysmal Nocturnal Hemoglobinuria Trial in Leeds (Pozelimab, Cemdisiran)

Recruiting
  • Paroxysmal Nocturnal Hemoglobinuria
  • Leeds, United Kingdom
    Regeneron Study Site
Apr 13, 2022

Paroxysmal Nocturnal Hemoglobinuria Trial in Whittier (Ravulizumab, Pozelimab, Cemdisiran)

Recruiting
  • Paroxysmal Nocturnal Hemoglobinuria
  • Whittier, California
  • +8 more
Nov 29, 2022

IgA Nephropathy (IgAN), Berger Disease, Glomerulonephritis, IgA Trial in Worldwide (Placebo, Cemdisiran)

Active, not recruiting
  • IgA Nephropathy (IgAN)
  • +2 more
  • Placebo
  • Cemdisiran
  • Vancouver, British Columbia, Canada
  • +19 more
Jan 13, 2023

Paroxysmal Nocturnal Hemoglobinuria Trial in Whittier (Cemdisiran, Eculizumab, Pozelimab)

Recruiting
  • Paroxysmal Nocturnal Hemoglobinuria
  • Cemdisiran
  • +3 more
  • Whittier, California
    Regeneron Research Facility
Jan 28, 2022

Healthy Trial in Antwerp (Pozelimab, Cemdisiran)

Completed
  • Healthy
  • Antwerp, Belgium
    Regeneron Research Site
Nov 11, 2021

Generalized Myasthenia Gravis Trial in Worldwide (Pozelimab + Cemdisiran, Cemdisiran, Placebo)

Recruiting
  • Generalized Myasthenia Gravis
  • Pozelimab + Cemdisiran
  • +3 more
  • Phoenix, Arizona
  • +46 more
Jan 31, 2023

Atypical Hemolytic Uremic Syndrome Trial in Ranica (cemdisiran, Placebos)

Withdrawn
  • Atypical Hemolytic Uremic Syndrome
  • cemdisiran
  • Placebos
  • Ranica, BG, Italy
    Centro di Ricerche Cliniche per le Malattie Rare " Aldo e Cele D
Mar 8, 2021

Atypical Hemolytic Uremic Syndrome Trial in Worldwide (Cemdisiran)

Withdrawn
  • Atypical Hemolytic Uremic Syndrome
  • Cemdisiran
  • Sarajevo, Bosnia and Herzegovina
  • +11 more
Sep 27, 2018